Literature DB >> 33098844

Giant Urticaria and Acral Peeling in a Child with Coronavirus Disease 2019.

Gioacchino Andrea Rotulo1, Sara Signa1, Silvia Rosina2, Carlotta Pastorino3, Elisabetta Bondi4, Mohamad Maghnie5.   

Abstract

Entities:  

Year:  2020        PMID: 33098844      PMCID: PMC7577291          DOI: 10.1016/j.jpeds.2020.10.039

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
A healthy 6-year-old girl presented with pruritic skin eruptions. The child was on the sixth day of isolation, with her mother suffering from a mild form of coronavirus disease 2019 (COVID-19) with ageusia and a single febrile episode. The next day, the child developed fever and pharyngodynia. In the emergency department, a nasal swab for severe acute respiratory syndrome coronavirus 2 (both molecular and antigen tests) was positive, and she was admitted to the COVID-19 unit of our institute. Skin examination revealed fleeting urticarial lesions lasting <24 hours and migrant appearance with polycyclic contours consistent with the diagnosis of acute viral giant urticaria (Figure, A-C). Two days after the onset of the skin lesions, a desquamation of the distal phalanges of the hands and feet appeared with cyanosis of the apical portion of the nail bed (Figure, D).
Figure

Giant urticaria. A-C, Fleeting orticarioid lesions with polycyclic contours. D, Desquamation of the distal phalanges of the hands.

Giant urticaria. A-C, Fleeting orticarioid lesions with polycyclic contours. D, Desquamation of the distal phalanges of the hands. The remaining physical examination and blood tests were unremarkable. No cardiac or respiratory abnormalities or signs suggestive of Kawasaki disease were evident. An oropharyngeal swab permitted us to rule out a streptococcal infection. The patient's fever disappeared quickly, lasting only 24 hours. Antihistamine therapy was given for symptomatic relief, with resolution of skin symptoms within 4 days. Mother and child were discharged in good general condition and continued isolation at home. Several clinical cases of suspected COVID-19 with skin involvement have been described in pediatric age, but most of them were unconfirmed cases.1, 2, 3, 4 The presence of acral peeling, not yet clearly described as a sign of COVID-19, in association with giant urticaria, should be emphasized in our confirmed pediatric case. Moreover, the skin manifestation was the first presenting sign of COVID-19, before the onset of fever. This must be taken into consideration to recognize a pediatric COVID-19 case early.
  2 in total

1.  Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.

Authors:  Jean Kanitakis; Cécile Lesort; Marie Danset; Denis Jullien
Journal:  J Am Acad Dermatol       Date:  2020-06-02       Impact factor: 11.527

2.  All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.

Authors:  Marco Denina; Francesco Pellegrino; Francesco Morotti; Paola Coppo; Ilaria Maria Bonsignori; Silvia Garazzino; Paolo Ravanini; Maria Avolio; Rossana Cavallo; Luigi Bertolotti; Enrico Felici; Gabriela Acucella; Davide Montin; Ivana Rabbone; Francesco Licciardi
Journal:  J Am Acad Dermatol       Date:  2020-08-08       Impact factor: 11.527

  2 in total
  4 in total

1.  Acral peeling as the sole skin manifestation of COVID-19 in children.

Authors:  David Andina-Martínez; Carmen Villaizán-Perez; María Rosa Pavo-García; Omar Suárez-Gómez; Ana Isabel Monzón-Bueno; Isabel Sanchez-Prieto; Pedro Viaño-Nogueira; Antonio Torrelo
Journal:  Pediatr Dermatol       Date:  2021-04-15       Impact factor: 1.997

Review 2.  Top 10 acral skin manifestations associated with COVID-19: A scoping review.

Authors:  Saeedeh Farajzadeh; Maryam Khalili; Shakiba Dehghani; Sharareh Babaie; Mahdi Fattah; Bahareh Abtahi-Naeini
Journal:  Dermatol Ther       Date:  2021-10-21       Impact factor: 3.858

Review 3.  Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.

Authors:  Marcello Lanari; Iria Neri; Arianna Dondi; Giacomo Sperti; Davide Gori; Federica Guaraldi; Marco Montalti; Lorenza Parini; Bianca Maria Piraccini
Journal:  Eur J Pediatr       Date:  2022-08-10       Impact factor: 3.860

Review 4.  Dermatological Manifestations of COVID-19 in Children.

Authors:  Maitreyee Panda; Akash Agarwal; Trashita Hassanandani
Journal:  Indian Pediatr       Date:  2022-03-10       Impact factor: 3.839

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.